2D'Angelo A. Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos. Semin Reprod Med, 2010, 28(6):513-8. 被引量：1
3Lee KH, Kim SH, Jee BC, et al. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Fertil Steril, 2010, 93(7):2274-80. 被引量：1
4Lien YR, Lu HF, Peng FS, et al. Factors associated with failure to achieve birth emphasizing a successful singleton at term following in vitro fertilization. Int J Gynaecol Obstet, 2010, 110(1):57-60. 被引量：1
5Luke B, Brown MB, Morbeck DE, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril, 2010, 94(4): 1399-404. 被引量：1
6Delvigne A. Symposium: update on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online, 2009, 19(1):8-13. 被引量：1
7Swanton A, Storey L, McVeigh E, et al. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol, 2010, 149(1):68-71. 被引量：1
8Kim YJ, Ku SY, Jee BC, et al. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles. Arch Gynecol Obstet, 2010, 282(2): 199-205. 被引量：1
9Liberty G, Ben-Chetrit A, Margalioth EJ, et al. Does estrogen directly modulate anti-Miillerian hormone secretion in women? Fertil Steril, 2010, 94(6):2253-6. 被引量：1
10Aflatoonian A, Oskouian H, Ahmadi S, et al. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mtillerian hormone versus small antral follicle count (2-6 mm). J Assist Repod Genet, 2009, 26(6):319-25,. 被引量：1
